Literature DB >> 10811292

Pseudomalabsorption of levothyroxine: a case report.

D Ogawa1, F Otsuka, U Mimura, A Ueno, H Hashimoto, M Kishida, T Ogura, H Makino.   

Abstract

A 51-year-old woman who had been treated with levothyroxine sodium because of hypothyroidism after total thyroidectomy for thyroidal cancer was admitted to our hospital for persistent hypothyroidism despite large dose administration of levothyroxine (600 microg/day). The patient complained of severe general fatigue and body weight gain. Free thyroxine, free triiodothyronine and thyrotropin levels were 0.97 ng/dl, 1.55 pg/ml and 24.51 microU/ml, respectively, under oral administration of levothyroxine. Levothyroxine loading test performed by liquid form, pulverized tablets via nasogastric tube and intravenous administration revealed no evidence of malabsorption or metabolic disorder of levothyroxine, although oral intake of tablets was ineffective due to her factitiousness. We report here a possible case of "pseudomalabsorption of levothyroxine" to emphasize the clinical recognition of this disorder in patients with resistant hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10811292     DOI: 10.1507/endocrj.47.45

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  9 in total

1.  Treatment-refractory hypothyroidism.

Authors:  Abdulaziz Ramadhan; Michael Tamilia
Journal:  CMAJ       Date:  2011-12-12       Impact factor: 8.262

2.  Pseudomalabsorption of Levothyroxine: A Challenge for the Endocrinologist in the Treatment of Hypothyroidism.

Authors:  Nancy Van Wilder; Bert Bravenboer; Sarah Herremans; Nathalie Vanderbruggen; Brigitte Velkeniers
Journal:  Eur Thyroid J       Date:  2016-11-24

3.  Once weekly thyroxine treatment as a strategy to treat non-compliance.

Authors:  S Rangan; A A Tahrani; A F Macleod; P K Moulik
Journal:  Postgrad Med J       Date:  2007-10       Impact factor: 2.401

4.  REFRACTORY HYPOTHYROIDISM TO LEVOTHYROXINE TREATMENT: FIVE CASES OF PSEUDOMALABSORPTION.

Authors:  O Elbasan; D Gogas Yavuz
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jul-Sep       Impact factor: 0.877

5.  A curious case of refractory hypothyroidism due to selective malabsorption of oral thyroxine.

Authors:  Nishikant Damle; Chandrasekhar Bal; Ramya Soundararajan; Praveen Kumar; Prashant Durgapal
Journal:  Indian J Endocrinol Metab       Date:  2012-05

Review 6.  Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report.

Authors:  M Centanni; S Benvenga; I Sachmechi
Journal:  J Endocrinol Invest       Date:  2017-07-10       Impact factor: 4.256

7.  Pituitary hyperplasia: a complication of the pseudomalabsorption of thyroxine.

Authors:  Mary-Anne Doyle; Heather A Lochnan
Journal:  Int J Gen Med       Date:  2013-04-29

8.  Subcutaneous application of levothyroxine as successful treatment option in a patient with malabsorption.

Authors:  Jan B Groener; Daniel Lehnhoff; David Piel; Peter P Nawroth; Jurik Schanz; Gottfried Rudofsky
Journal:  Am J Case Rep       Date:  2013-02-20

9.  Rapid Levothyroxine Absorption Testing: A Case Series of Nonadherent Patients.

Authors:  Mamtha Balla; Ram M Jhingan; Daniel J Rubin
Journal:  Int J Endocrinol Metab       Date:  2015-10-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.